An influence of small doses of corticosteroids on immune defense in active pulmonary tuberculosis in humans

B. Rybacka-Chabros, J. Milanowski (Lublin, Poland)

Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Session: Clinical immunology of tuberculosis
Session type: Thematic Poster Session
Number: 2569
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Rybacka-Chabros, J. Milanowski (Lublin, Poland). An influence of small doses of corticosteroids on immune defense in active pulmonary tuberculosis in humans. Eur Respir J 2009; 34: Suppl. 53, 2569

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Could pulmonary tuberculosis present without any inflammatory response?
Source: Eur Respir J 2005; 26: Suppl. 49, 420s
Year: 2005

The effect of oral zinc sulphate on immune system of patients with pulmonary tuberculosis
Source: Annual Congress 2008 - Miscellaneous respiratory infections
Year: 2008


Monitoring T-cell immunity towards M. tuberculosis: impaired specific immunocompetence in patients receiving high levels of immunosuppressive drugs
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 15s
Year: 2002

Role of adaptive immunity in clinical variability of active tuberculosis patients
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021


Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007


Inflammatory phenotypes of asthma determine effect of inhaled corticosteroids on anti-viral immunity
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020




Pulmonary defence mechanisms and inflammatory pathways in bronchiectasis
Source: Eur Respir Mon 2011; 52: 11-21
Year: 2011


Organised local immune response in the lungs of patients with tuberculosis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009

Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009

Oral commensals in the lower airways of COPD leads to an altered host immune tone
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020

The effect of antituberculosis chemotherapy on thyroid hormones in active pulmonary tuberculosis patients
Source: Eur Respir J 2001; 18: Suppl. 33, 306s
Year: 2001

The status of populations of cell-mediated lung immunity effectors after chemotherapy of experimental MDR tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 656s
Year: 2005

Improving the innate immune response in respiratory infections: the use of repurposed drugs
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020


How infections can modify lung immunity
Source: Eur Respir J 2001; 18: 442-443
Year: 2001


Evolution of systemic response in patients with pulmonary sarcoidosis of different course of the disease during anti-inflammatory treatment
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009

How infections can modify lung immunity
Source: Guideline 2001
Year: 2001

Significance of circulating immune complexes in pulmonary tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011